InvestorsHub Logo
Followers 90
Posts 2658
Boards Moderated 0
Alias Born 04/04/2008

Re: Garden Rose post# 35906

Wednesday, 06/28/2017 5:13:24 PM

Wednesday, June 28, 2017 5:13:24 PM

Post# of 113741
IMO, a $1B valuation would be for all 27 generics coming to market in CA, and not include any pre-clinical cancer meds (as pre-clinical meds are not worth anything until proven).

The PR released on the 19th states they have filed for a DEL which means they are not licensed to handle drug manufacturing yet. This is really in the very beginning stages of becoming a working pharma company.

Still DDing, but seems very interesting...

We're all on our way out, act accordingly...

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News